Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GABRA1 | P14867 | 1/20 | 0.59 |
| ▸ | GABRB2 | P47870 | 1/20 | 0.59 |
| ▸ | ELANE | P08246 | 1/20 | 0.58 |
| ▸ | IDO1 | P14902 | 1/20 | 0.56 |
| ▸ | ALOX5 | P09917 | 2/20 | 0.54 |
| ▸ | PTGS2 | P35354 | 1/20 | 0.54 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.53 |
| ▸ | MEN1 | O00255 | 2/20 | 0.53 |
| ▸ | HTT | P42858 | 2/20 | 0.53 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.52 |
| ▸ | MAPT | P10636 | 2/20 | 0.52 |
| ▸ | MAPK1 | P28482 | 2/20 | 0.52 |
| ▸ | CYP3A4 | P08684 | 2/20 | 0.52 |
| ▸ | LMNA | P02545 | 1/20 | 0.52 |
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | HPGD | P15428 | 1/20 | 0.52 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.52 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1245192 | 1.00 | GABRA1 (0.59) | GABRA1GABRB2ELANEIDO1ALOX5 | |
| SCHEMBL6720308 | 0.89 | ELANE (0.52) | GABRA1GABRB2ELANEIDO1ALOX5 | |
| SCHEMBL5659189 | 0.85 | GABRA1 (0.63) | GABRA1GABRB2ELANEKDM4EMEN1 | |
| SCHEMBL10433454 | 0.83 | KDM4E (0.56) | GABRA1GABRB2ELANEKDM4EMEN1 | |
| SCHEMBL11215632 | 0.82 | ELANE (0.55) | GABRA1GABRB2ELANEALOX5KDM4E | |
| SCHEMBL2477378 | 0.82 | TLR2 (0.56) | ELANEIDO1ALOX5PTGS2KDM4E | |
| SCHEMBL8074013 | 0.82 | GABRA1 (0.59) | GABRA1GABRB2ELANEKDM4EMEN1 | |
| SCHEMBL9268988 | 0.82 | GABRA1 (0.59) | GABRA1GABRB2ELANEIDO1KDM4E | |
| SCHEMBL9240445 | 0.81 | GABRA1 (0.54) | GABRA1GABRB2ELANEKDM4EMEN1 | |
| SCHEMBL29890976 | 0.81 | IDO1 (0.52) | GABRA1GABRB2IDO1ALOX5KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 35 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-115697951-B | Method for producing para-eugenol and/or ortho-eugenol | 法国特种经营公司 | 2025-02-11 | — | — | CN | claimed |
| US-20230118184-A1 | PROCESS FOR PRODUCING PARA-EUGENOL AND/OR ORTHO-EUGENOL | RHODIA OPERATIONS (FR) | 2023-04-20 | — | — | US | claimed |
| EP-4126804-A1 | PROCESS FOR PRODUCING PARA-EUGENOL AND/OR ORTHO-EUGENOL | RHODIA OPERATIONS (FR) | 2023-02-08 | — | — | EP | claimed |
| US-20220234979-A1 | PROCESS FOR THE PURIFICATION OF EUGENOL AND NOVEL COMPOSITIONS COMPRISING EUGENOL | SPECIALTY OPERATIONS FRANCE (FR) | 2022-07-28 | — | — | US | claimed |
| EP-4719751-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2026-04-08 | — | — | EP | disclosed |
| EP-4719753-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2026-04-08 | — | — | EP | disclosed |
| EP-4719750-A1 | EMBEDDED HYDROGEL CONTACT LENSES | Alcon Inc. (CH) | 2026-04-08 | — | — | EP | disclosed |
| EP-3661902-B1 | METHOD FOR THE DEACYLATION AND/OR DEALKYLATION OF COMPOUNDS | UNIV ANTWERPEN (BE) | 2025-07-16 | — | — | EP | disclosed |
| CN-115697951-B | Method for producing para-eugenol and/or ortho-eugenol | 法国特种经营公司 | 2025-02-11 | — | — | CN | disclosed |
| CN-115697951-B | Method for producing para-eugenol and/or ortho-eugenol | 法国特种经营公司 | 2025-02-11 | — | — | CN | disclosed |
| US-20240410055-A1 | METHOD AND FORMULATION FOR PREPARING OPTICAL METAL OXIDE LAYERS | MERCK PATENT GMBH (DE) | 2024-12-12 | — | — | US | disclosed |
| WO-2024246819-A1 | METHOD FOR MAKING EMBEDDED HYDROGEL CONTACT LENSES | ALCON INC. (CH) | 2024-12-05 | — | — | WO | disclosed |
| EP-4126804-A1 | PROCESS FOR PRODUCING PARA-EUGENOL AND/OR ORTHO-EUGENOL | RHODIA OPERATIONS (FR) | 2023-02-08 | — | — | EP | disclosed |
| WO-2022201013-A1 | POLYSILOXANE VINYLIC CROSSLINKERS WITH HIGH REFRACTIVE INDEX | ALCON INC. (CH) | 2022-09-29 | — | — | WO | disclosed |
| US-20220234979-A1 | PROCESS FOR THE PURIFICATION OF EUGENOL AND NOVEL COMPOSITIONS COMPRISING EUGENOL | SPECIALTY OPERATIONS FRANCE (FR) | 2022-07-28 | — | — | US | disclosed |
| US-20220234979-A1 | PROCESS FOR THE PURIFICATION OF EUGENOL AND NOVEL COMPOSITIONS COMPRISING EUGENOL | SPECIALTY OPERATIONS FRANCE (FR) | 2022-07-28 | — | — | US | disclosed |
| EP-3999344-A1 | METHOD OF ATOMIZING A FLUID COMPOSITION | The Procter & Gamble Company (US) | 2022-05-25 | — | — | EP | disclosed |
| EP-3999241-A1 | METHOD OF ATOMIZING A FLUID COMPOSITION | The Procter & Gamble Company (US) | 2022-05-25 | — | — | EP | disclosed |
| EP-3999125-A1 | FRESHENING COMPOSITIONS AND METHODS OF ATOMIZING FRESHENING COMPOSITIONS WITH A THERMALLY-ACTUATED MICROFLUIDIC CARTRIDGE | The Procter & Gamble Company (US) | 2022-05-25 | — | — | EP | disclosed |
| EP-3969434-A1 | PROCESS FOR THE PURIFICATION OF EUGENOL AND NOVEL COMPOSITIONS COMPRISING EUGENOL | Rhodia Operations (FR) | 2022-03-23 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20220234979-A1 | PROCESS FOR THE PURIFICATION OF EUGENOL AND NOVEL COMPOSITIONS COMPRISING EUGENOL | LAGE3, OSTC, OSBP | GABRA1 2674/4885GABRB2 3014/4885ELANE 232/4885 |
| US-20230118184-A1 | PROCESS FOR PRODUCING PARA-EUGENOL AND/OR ORTHO-EUGENOL | CYP8B1, POR, CYP1A1 | GABRA1 1449/4885GABRB2 1706/4885ELANE 392/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.